Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02903160
Recruitment Status : Recruiting
First Posted : September 16, 2016
Last Update Posted : November 19, 2020
Sponsor:
Collaborators:
Sanofi
Bayer
Information provided by (Responsible Party):
Bobby Liaw, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : November 2021